IFNB1 and coronary artery disorder: The observed metabolic adaptations resulted in reduced hepatocyte functionality and resistance to oxidants, features that may play key roles in the accelerated liver pathology in CHD and give important clues regarding the effects of IFN-β on liver physiology.